Azenta (Azenta) Order Backlog for Technology (USD Mil) : 430.00 (As of Sep. 2019)

View and export this data going back to 1995. Start your Free Trial

What is Azenta Order Backlog for Technology (USD Mil)?

Backlog of orders refers to the quantity and combined monetary value of the products which have been ordered by customers but which have not shipped yet.

Azenta's Order Backlog for Technology (USD Mil) for the quarter that ended in Sep. 2019 was 430.00 , which higher from pervious quarter (Sep. 2018)'s result by 8.31%.

Azenta's Order Backlog for Technology (USD Mil) for the annual that ended in Sep. 2020 was 502.00 , which higher from pervious year (Sep. 2019)'s result by 16.74%.

The historical rank and industry rank for Azenta's Order Backlog for Technology (USD Mil) or its related term are showing as below:

AZTA's Order Backlog for Technology (USD Mil) is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Order Backlog for Technology (USD Mil) only.

Azenta Order Backlog for Technology (USD Mil) Historical Data

The historical data trend for Azenta's Order Backlog for Technology (USD Mil) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Order Backlog for Technology (USD Mil) Chart

Azenta Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Order Backlog for Technology (USD Mil)

Get a 7-Day Free Trial

AzentaQuarterly Data

Trend

Jun16

Sep16

Dec16

Mar17

Jun17

Sep17

Dec17

Mar18

Sep18

Sep19

Order Backlog for Technology (USD Mil)

Get a 7-Day Free Trial

Bookings (USD Mil)

Get a 7-Day Free Trial

Competitive Comparison of Azenta's Order Backlog for Technology (USD Mil)

For the Medical Instruments & Supplies subindustry, Azenta's Order Backlog for Technology (USD Mil), along with its competitors' market caps and Order Backlog for Technology (USD Mil) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Azenta (NAS:AZTA) Order Backlog for Technology (USD Mil) Explanation

The term backlog refers to a buildup of work that has not yet been completed by the company. The presence of a backlog can have positive or negative implications. For example, a rising backlog of product orders might indicate rising sales. On the other hand, companies generally want to avoid having a backlog as it could cause (or be a result of) increasing inefficiency in the production process. Likewise, a falling backlog might be a sign of lagging demand but could also be a result of improving production efficiency. Naturally, unexpected backlogs can compromise forecasts and production schedules.

Azenta Order Backlog for Technology (USD Mil) Related Terms

Thank you for viewing the detailed overview of Azenta's Order Backlog for Technology (USD Mil) provided by GuruFocus.com. Please click on the following links to see related term pages.

Azenta (Azenta) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (NAS:AZTA) » Definitions » Order Backlog for Technology (USD Mil)

Comparable Companies

Traded in Other Exchanges

BA3:Germany

Address

200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803

Website

https://www.azenta.com

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

Executives

Herman Cueto	officer: EVP, Chief Financial Officer	C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
Violetta Hughes	officer: VP, Chief Accounting Officer	C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
David C Gray	officer: Chief Strategy & New Business	C/O GT SOLAR INTERNATIONAL, INC., 243 DANIEL WEBSTER HIGHWAY, MERRIMACK NH 03054
Joseph R Martin	director
Dorothy E Puhy	director	DANA FARBER CANCER INSTITUTE, 44 BINNEY STREET, RM. D1632, BOSTON MA 02115
Tina Susan Nova	director	C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Mitchell Coyne	officer: SVP and GM, Life Sciences Proj	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Ginger Zhou	officer: SVP and General Manager, Genom	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Matthew Mcmanus	officer: EVP & Chief Operating Officer	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Lindon G Robertson	officer: EVP & Chief Financial Officer	C/O GRAFTECH INTERNATIONAL LTD., 12900 SNOW ROAD, PARMA OH 44130
Kimberly Crowley	officer: Chief Human Resources Officer	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Vandana Sriram	officer: VP, Finance & Corp. Controller	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Jesus Linda De	officer: Chief Commercial Officer, LS	15 ELIZABETH DRIVE, CHEMSFORD MA 01824
David Jarzynka	officer: Sr. VP, General Manager	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Robin Vacha	officer: SVP, GM BLS-Products	15 ELIZABETH DRIVE, 15 ELIZABETH DRIVE, CHELMSFORD MA 01824